Chemotherapy-Related Toxicities In Ovarian Cancer Patients: Preference Assessments of Patients, Family Members, Ancillary Staff and Gynecologic Oncologists, and Patients' Quality of Life
18 Years
N/A
Female
Ovarian Cancer
Trial Information
Chemotherapy-Related Toxicities In Ovarian Cancer Patients: Preference Assessments of Patients, Family Members, Ancillary Staff and Gynecologic Oncologists, and Patients' Quality of Life
Patients in this study will be recruited from the Gynecologic Oncology Clinic waiting area.
All participants (patients, family and clinical caregivers, control group women with no
cancer) in this study will take part in an interview to see how they feel about the
different side-effects of chemotherapy. The interview will involve reading short
descriptions of the side-effects and then answering some questions that ask for an opinion.
The actual interview will take about 30-45 minutes to complete. The interviews will either
take place in private conference rooms in the clinic or in private rooms at the Ambulatory
Treatment Center (ATC).
Patients will also be given quality of life and symptom assessment questionnaires. The
questionnaires are simple to read and quick to answer. The questionnaire takes about 15
minutes to complete.
The participant's involvement in this study is limited to the questionnaire/interview. Once
that is done, the participant is finished with the study.
This is an investigational study. A total of 288 people will take part in this study. All
will be enrolled at M. D. Anderson.
Inclusion Criteria:
1. Women with epithelial ovarian cancer presenting to the UTMDACC Gynecologic Oncology
Clinic who are currently undergoing chemotherapy
2. Women with a history of epithelial ovarian cancer presenting to the UTMDACC
Gynecologic Oncology Clinic who are seen in follow-up
3. Women who are at least 18 years of age
4. Women who speak English
5. Clinical caregivers of patients with ovarian cancer (UTMDACC gynecologic oncologists,
UTMDACC gynecologic medical oncologists, UTMDACC registered nurses and licensed
vocational nurses in the UTMDACC Gynecology Clinic, and UTMDACC gynecologic oncology
fellows and residents)
6. Familial caregivers of patients with ovarian cancer (primary caregiver)
Exclusion Criteria:
1. Participants who are non-English speakers
2. Participants who are less than 18 years of age
Type of Study:
Observational
Study Design:
Observational Model: Case-Only, Time Perspective: Prospective
Outcome Measure:
Qualitative information on how ovarian cancer patients, their family members, and doctors and nurses feel about the side-effects of chemotherapy.
Outcome Time Frame:
8 Years
Safety Issue:
No
Principal Investigator
Diane C. Bodurka, MD
Investigator Role:
Principal Investigator
Investigator Affiliation:
M.D. Anderson Cancer Center
Authority:
United States: Institutional Review Board
Study ID:
GYN00-409
NCT ID:
NCT00508378
Start Date:
January 2001
Completion Date:
Related Keywords:
- Ovarian Cancer
- Ovarian Cancer
- Quality of Life
- Chemotherapy Side-Effects
- Interview
- Questionnaire
- Caregivers
- Ovarian Neoplasms
Name | Location |
|---|---|
| UT MD Anderson Cancer Center | Houston, Texas 77030 |
